viernes, 30 de enero de 2026

Direct-to-Consumer Drug Program: New OIG Safeguards for Federal Program Enrollees January 30, 2026 By Julie Kim & Jeffrey N. Wasserstein —

https://www.thefdalawblog.com/2026/01/direct-to-consumer-drug-program-new-oig-safeguards-for-federal-program-enrollees/?utm_source=rss&utm_medium=rss&utm_campaign=direct-to-consumer-drug-program-new-oig-safeguards-for-federal-program-enrollees

No hay comentarios: